Breast Cancer,HER2- Neoadjuvant Zanidatamab Is Safe And Effective In Stage I Node Negative HER2+ BC Sep 15, 2023
Breast Cancer,HER2- Autologous TAC01-HER2 Proves Safe And Effective In Relapsed Or Refractory Solid Tumors Sep 12, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Combined Therapy of Pembrolizumab and Mifepristone in Advanced HER2-Negative Breast Cancer Sep 08, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) HER2+ Early Breast Cancer: T-DM1 + Pertuzumab vs. Taxane + Trastuzumab + Pertuzumab After Anthracycline Aug 30, 2023
TNBC (Triple Negative Breast Cancer) Association of 18-GEP With Clinical Outcomes in mTNBC Pts Treated With Pembro or Chemo Aug 23, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Inflammatory Profiling Of Individuals With gTP53m To Predict New Subsequent Cancers Aug 22, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) A Study Of Expression Levels Of IC Markers In HR+/HER2- MBC Aug 21, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) BMI's Impact on Postmenopausal HR+ Breast Cancer Patients in Extended Endocrine Therapy Aug 18, 2023
